Department of Cardiovascular Radiology, Hôpital Pradel, Hospices Civils de Lyon, Lyon, France.
University Claude Bernard Lyon 1, Lyon, France.
Eur Radiol. 2024 Jan;34(1):214-225. doi: 10.1007/s00330-023-09940-2. Epub 2023 Aug 2.
To evaluate the prevalence of intra-myocardial fatty scars (IMFS) most likely indicating previous silent myocardial infarction (SMI), as detected on coronary artery calcium (CAC) computed tomography (CT) scans in diabetic patients without history of coronary heart disease (CHD).
Diabetic patients screened for silent coronary insufficiency in a tertiary-care, university hospital between Jan-2015 and Dec-2016 were categorized according to their CAC score in two groups comprising 242 patients with CACS = 0 and 145 patients with CACS ≥ 300. CAC-CT scans were retrospectively evaluated for subendorcardial and transmural IMFS of the left ventricle. Adipose remodeling, patients' characteristics, cardiovascular risk factors and metabolic profile were compared between groups.
Eighty-three (21%) patients with IMFS were identified, 55 (37.9%) in the group CACS ≥ 300 and 28 (11.6%) in the CACS = 0 (OR = 4.67; 95% CI = 2.78-7.84; p < 0.001). Total and average surface of IMFS and their number per patient were similar in both groups (p = 0.55; p = 0.29; p = 0.61, respectively). In the group CACS ≥ 300, patients with IMFS were older (p = 0.03) and had longer-lasting diabetes (p = 0.04). Patients with IMFS were older and had longer history of diabetes, reduced glomerular filtration rate, more coronary calcifications (all p < 0.05), and higher prevalence of carotid plaques (OR = 3.03; 95% CI = 1.43-6.39, p = 0.004). After correction for other variables, only a CACS ≥ 300 (OR = 5.12; 95% CI = 2.66-9.85; p < 0.001) was associated with an increased risk of having IMFS.
In diabetic patients without known CHD, IMFSs were found in patients without coronary calcifications, although not as frequently as in patients with heavily calcified coronary arteries. It remains to be established if this marker translates in an upwards cardiovascular risk restratification especially in diabetic patients with CACS = 0.
In diabetic patients without history of coronary heart disease, intramyocardial fatty scars, presumably of post-infarction origin, can be detected on coronary artery calcium CT scans more frequently, but not exclusively, if the coronary arteries are heavily calcified as compared to those without calcifications.
• Intramyocardial fatty scars (IMFS), presumably of post-infarction origin, can be detected on coronary artery calcium (CAC) CT scans more frequently, but not exclusively, in diabetic patients with CACS ≥ 300 as compared to patients CACS = 0. • Patients with IMFS were older and had longer history of diabetes, reduced glomerular filtration rate, and more coronary calcifications. • Carotid plaques and CACS ≥ 300 were associated with an increased risk of having IMFS, about three and five folds respectively.
评估在没有冠心病 (CHD) 病史的糖尿病患者的冠状动脉钙 (CAC) 计算机断层扫描 (CT) 上检测到的心肌内脂肪疤痕 (IMFS) 的发生率,这些疤痕最有可能表明之前发生过无症状性心肌梗死 (SMI)。
在 2015 年 1 月至 2016 年 12 月期间,在一家三级保健、大学医院对无症状性冠状动脉功能不全的糖尿病患者进行筛查,根据他们的 CAC 评分将患者分为两组:242 例 CAC=0 和 145 例 CAC≥300。回顾性评估 CAC-CT 扫描以确定左心室心内膜下和透壁性 IMFS。比较两组之间的脂肪重构、患者特征、心血管危险因素和代谢特征。
共发现 83 例(21%)有 IMFS 的患者,CAC≥300 组中 55 例(37.9%),CAC=0 组中 28 例(11.6%)(OR=4.67;95%CI=2.78-7.84;p<0.001)。两组之间的总和平均 IMFS 表面积及其每位患者的数量相似(p=0.55;p=0.29;p=0.61,分别)。在 CAC≥300 组中,有 IMFS 的患者年龄较大(p=0.03)且糖尿病病程较长(p=0.04)。有 IMFS 的患者年龄较大,糖尿病病史较长,肾小球滤过率降低,冠状动脉钙化程度更严重(所有 p<0.05),颈动脉斑块的发生率更高(OR=3.03;95%CI=1.43-6.39,p=0.004)。在对其他变量进行校正后,只有 CAC≥300(OR=5.12;95%CI=2.66-9.85;p<0.001)与发生 IMFS 的风险增加相关。
在没有已知 CHD 的糖尿病患者中,在没有冠状动脉钙化的患者中也可以发现 IMFS,尽管不如在冠状动脉严重钙化的患者中常见。在 CAC=0 的糖尿病患者中,这种标志物是否会导致心血管风险的重新分层增加,特别是在 CAC=0 的糖尿病患者中,还有待确定。
在没有冠心病病史的糖尿病患者中,通过冠状动脉钙 CT 扫描可以更频繁地检测到心肌内脂肪疤痕(IMFS),推测是梗死后的疤痕,但与无钙化的患者相比,仅在冠状动脉严重钙化的患者中更为常见。
在 CAC≥300 的糖尿病患者中,通过冠状动脉钙 (CAC) CT 扫描可以更频繁地检测到心肌内脂肪疤痕 (IMFS),而在 CAC=0 的患者中则不然。
有 IMFS 的患者年龄较大,且糖尿病病史较长,肾小球滤过率降低,冠状动脉钙化程度更严重。
颈动脉斑块和 CAC≥300 与发生 IMFS 的风险增加相关,分别为 3 倍和 5 倍。